Cancer Tumor Profiling Market Report 2027 on Outlook, Current Trends, Industry Analysis, Insights, Share, and Forecasts

by Emergen Research · March 17, 2023

Cancer Tumor Profiling Market

A recent analysis by Emergen Research projects that the market for cancer tumour profiling would reach USD 31.99 billion by 2027. The increased acceptance of proteomic approaches for biomarker research and the increasing use of biomarkers in cancer profiling are both credited with driving this market’s rise throughout the forecasted time frame. The increasing desire for personalised treatment and the increase in cancer incidence around the world are boosting the industry’s demand. The World Health Organization (WHO) reports that there are about 2.09 million instances of lung and breast cancer annually. For the anticipated period, the market will be driven by the rising need for malignant tumour profiling.

After carefully analysing the vital commercial data and broad geographic dispersion of the business, Emergen Research created a market research study on cancer tumour profiling. The study provides in-depth coverage of the qualitative and quantitative analysis of the market for cancer tumour profiling as well as important market statistics. The study paper offers current estimates through 2020 as well as historical data from 2018 to 2019. The profiles of both well-known and emerging industry participants in the research contain a summary of the company, product portfolio, strategic relationships, and corporate expansion goals.

To receive a PDF sample of the report, visit @ https://www.emergenresearch.com/request-sample/50

Global Cancer Tumor Profiling Market Highlights:

Regional demand estimation and forecast
Product Mix Matrix
R&D Analysis
Cost-Benefit Analysis
Pre-commodity pricing volatility
Supply chain optimization analysis
Technological updates analysis
Raw Material Sourcing Strategy
Competitive Analysis
Mergers & Acquisitions
Location Quotients Analysis
Carbon Footprint Analysis
Patent Analysis
Vendor Management

Competitive Landscape:

The latest study provides an insightful analysis of the broad competitive landscape of the global Cancer Tumor Profiling market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report. The report analyzes various elements of the market’s competitive scenario, such as the regulatory standards and policies implemented across the industry over recent years. Our team of experts has leveraged several powerful analytical tools, such as Porter’s Five Forces analysis and SWOT analysis, to deliver a comprehensive overview of the global Cancer Tumor Profiling market and pinpoint the fundamental growth trends.

Key Companies Profiled in the Report are:

Caris Life Sciences, Foundation Medicine, GenomeDX, Genomic Health, Guardant Health, Helomics Corporation, HTG Molecular Diagnostics, Inc., Nanostring Technologies, Neogenomics Inc., Oxford Gene Technology, Qiagen N.V., Ribomed Biotechnologies.

Key Parameters Analyzed in This Section:

Company Profiles
Gross Revenue
Profit margins
Product sales trends
Product pricing
Industry Analysis
Sales & distribution channels

Regional Segmentation:

North America
Latin America
Europe
Middle East & Africa
Asia Pacific

Key Points Covered in This Section:

Regional contribution
Estimated revenue generation
Vital data and information about the consumption rate in all the leading regional segments
An expected rise in market share
Forecast growth in the overall consumption rate

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends @ https://www.emergenresearch.com/industry-report/cancer-tumor-profiling-market

Some Key Highlights from the Report

The Genomics segment was valued at 2.76 Billion in 2019, owing to the rise in the research institutes’ funding for developing modified medicine is expected to increase the demand for the genomics industry. The use of genomics technology by various companies for cancer tumor profiling is anticipated to increase the overall genomics industry’s demand for the upcoming forecast period.
Asia Pacific countries such as China, India, and Japan, have seen a striking increase in cancer tumor profiling. Developing economies, including India, Singapore, and Korea, are anticipated to intensify global demand.
High investments by companies to launch new products for cancer tumor profiling with various advancement in the new technique is augmented to propel the market. For instance, in May 2019, QIAGEN, launched therascreen PIK3CA RGQ PCR Kit as a companion diagnostic to aid in identifying breast cancer patients.
Immunoassays segments are seen to have the largest market share in 2019. The Immunoassays technology is used to detect tumors with applications in Oncological Diagnostics, Prognostics, Monitoring and Treatment, and Screening.
In 2019, the Research Application segment was valued at USD 5.67 Billion owing to the rise in the research and development, increasing demand for personalized medicine. The use of cancer tumor profiling helps to decide whether the patients require a diagnostic test. Furthermore, advancement in molecular biology is one of the factors to boost market growth.
The North America regional section held the most extensive share in the Cancer tumor profiling industry, with 37.2% in 2019. The industry is dominated in this region due to substantial growth in clinical and research applications and key players in the region.

Market Overview:

The report bifurcates the Cancer Tumor Profiling market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.

Segments Covered in this report are:

Technique Type Outlook (Revenue, USD Billion; 2017-2027)
- Genomics
- Epigenetics
- Metabolomics
- Proteomics

Technology Outlook (Revenue, USD Billion; 2017-2027)
- Immunoassays
- In Situ Hybridization
  1. Fluorescence In Situ Hybridization (FISH)
  2. Chromogenic In Situ Hybridization (CISH)
- Microarray
- Polymerase Chain Reaction (PCR)
- Sequencing Technologies
  1. Next Generation Sequencing(NGS)
  2. Pyro Sequencing
  3. Sanger Sequencing
- Other Technologies

Application Outlook (Revenue, USD Billion; 2017-2027)
- Research Application
  1. Biomarker Discovery
  2. Personalized Cancer Medicine
- Clinical Application
  1. Oncological Diagnostics
  2. Prognostics
  3. Monitoring and Treatment
  4. Screening

To seek a discount on this report, visit @ https://www.emergenresearch.com/request-discount/50

Additional information offered by the report:

Along with a complete overview of the global Cobots market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
The report elaborates on the global Cobots market size and share governed by the major geographies.
It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
It further presents a detailed description of the company profiles of the key market contenders.

Request Customization as per your specific requirement @ https://www.emergenresearch.com/request-for-customization/50

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Latest Published Reports by Emergen Research:

cloud backup & recovery market

https://www.emergenresearch.com/industry-report/cloud-backup-recovery-market

hd maps for autonomous vehicles market

https://www.emergenresearch.com/industry-report/hd-maps-for-autonomous-vehicles-market

iot security market

https://www.emergenresearch.com/industry-report/iot-security-market

rtv silicone market

https://www.emergenresearch.com/industry-report/rtv-silicone-market

food antioxidants market

https://www.emergenresearch.com/industry-report/food-antioxidants-market

image recognition market

https://www.emergenresearch.com/industry-report/image-recognition-market

feldspar market

https://www.emergenresearch.com/industry-report/feldspar-market

fluid transfer system market

https://www.emergenresearch.com/industry-report/fluid-transfer-system-market

threat intelligence market

https://www.emergenresearch.com/industry-report/threat-intelligence-market

silicon wafer market

https://www.emergenresearch.com/industry-report/silicon-wafer-market

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Latest Report: 3d printing metal market, vaccine market